Afghanistan vs Kyrgyzstan: Adults (ages 15+) and children (0-14 years) living with HIV
Afghanistan
13,000
in 2024
Kyrgyzstan
13,000
in 2024
Afghanistan rank
91st
Kyrgyzstan rank
91st
Adults (ages 15+) and children (0-14 years) living with HIV over time
- Afghanistan
- Kyrgyzstan
How they compare
Afghanistan currently reports 13,000 against 13,000 in Kyrgyzstan, a difference of 0.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Afghanistan ahead.
Afghanistan ranks 91st and Kyrgyzstan ranks 91st of 152 countries.
Across the 4 decades both report, Afghanistan averaged higher in 2 and Kyrgyzstan in 2.
Head to head by decade
| Decade | Afghanistan | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 811 | 100 | 711 | Afghanistan |
| 2000s | 2,440 | 1,615 | 825 | Afghanistan |
| 2010s | 6,340 | 7,210 | 870 | Kyrgyzstan |
| 2020s | 11,380 | 12,000 | 620 | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher adults (ages 15+) and children (0-14 years) living with hiv, Afghanistan or Kyrgyzstan?
- Afghanistan, at 13,000 against 13,000 in Kyrgyzstan as of 2024.
- What is the difference in adults (ages 15+) and children (0-14 years) living with hiv between Afghanistan and Kyrgyzstan?
- 0, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Kyrgyzstan?
- 35 years are reported by both, from 1990 to 2024.
- How do Afghanistan and Kyrgyzstan rank globally for adults (ages 15+) and children (0-14 years) living with hiv?
- Afghanistan ranks 91st and Kyrgyzstan ranks 91st of 152 countries.
- Where does this data come from?
- UNAIDS estimates, published as Adults (ages 15+) and children (0-14 years) living with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Adults and children living with HIV refers to the number of people ages 0-49 (adult ages 15-49 and children ages 0-14) who are infected with HIV.